| |
|
|
|
Aptevo Therapeutics Inc.  
|
|
0.63 0.016 (0.03%) |
11-20 16:00 |
|
Open: |
0.6103 |
Pre close: |
0.6145 |
Target:
|
0.86 
|
|
High: |
0.6379 |
Low: |
0.603 |
Resistance:
|
0.74
0.86
|
|
Volume: |
124,427 |
Market Cap: |
29M |
Support:
|
0.60
0.51
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.62
 |
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
0.61 |
Signal(12,26,9): |
0.00 |
|
MA(100): |
0.72 |
Stochastic Oscillator |
%K(14,3):
|
46.52 |
|
MA(250): |
1.03 |
%D(3): |
46.02 |
|
Average Volume(K) |
3-Month: |
35399
|
52-Week |
High:
|
2.73 |
|
10-Days: |
39680 |
Low: |
0.49 |
|
RSI |
RSI(14):
|
51.12 |
Change(%): |
-76.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.319 |
Return on Equity (ttm) |
-155.8 |
Shares Out. (M) |
45.28 |
|
EPS Est. Current Year |
0.590 |
Return on Assets (ttm) |
-43.4 |
Shares Float (M) |
31.87 |
|
EPS Est. Next Year |
-2.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.31 |
|
EPS Est. Next Quarter |
2.250 |
Qtrly Rev. Growth |
54.7 |
% Held by Institutions |
41.88 |
|
Forward EPS |
-1.321 |
Gross Profit (p.s.) |
-0.520 |
Shares Short (K) |
1250 |
|
Book Value (p.s.) |
0.440 |
EBITDA (p.s.) |
-1.020 |
P/E |
-0.48 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.43 |
|
Profit Margin |
-156.03 |
Operating Cash Flow
(M) |
-44.58 |
P/S |
0.74 |
|
Operating Margin |
-163.01 |
Levered Free Cash Flow
(M) |
-21.58 |
P/CF |
-0.64 |
|
|
|
|
|
|
